ResearcherShanghai Jiao Tong UniversityNo recent work listed
Manmei Long
Matched on OpenAlex author ID A5102334448. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper
Papers 3
- miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Co-author DOI 10.1080/15384101.2020.1831254↗
- miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Co-author DOI 10.1038/cddis.2017.530↗
- miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Co-author DOI 10.1186/s12943-017-0723-7↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ming Zhan · 3 shared papers, 2017–2020 · strength 0.24
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Paper miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. DOI 10.1186/s12943-017-0723-7↗
- Ruimeng Yang · 3 shared papers, 2017–2020 · strength 0.24
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Paper miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. DOI 10.1186/s12943-017-0723-7↗
- Linhua Yang · 2 shared papers, 2017–2020 · strength 0.18
- Jian Wang · 2 shared papers, 2017 · strength 0.13
- Qiang Liu · 2 shared papers, 2017 · strength 0.13
- Hui Wang · 1 shared paper, 2020 · strength 0.11
- Rong Yue Cao · 1 shared paper, 2020 · strength 0.11
- Shuai Huang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.